Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxysafflor yellow A for injection in acute ischemic stroke
CTR20201900Phase 3Completed
- Sponsor
- Tiansanqi
- Start
- Oct 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxysafflower yellow a in ischemic stroke, sponsored by Tiansanqi. Started Oct 2020; status: completed.
02
Drugs
hydroxysafflower yellow a
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20201900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201900.